Electrocardiographic Comparison of Ventricular Arrhythmias in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy and Right Ventricular Outflow Tract Tachycardia
Overview
Authors
Affiliations
Objectives: The purpose of this study was to evaluate whether electrocardiographic characteristics of ventricular arrhythmias distinguish patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) from those with right ventricular outflow tract tachycardia (RVOT-VT).
Background: Ventricular arrhythmias in RVOT-VT and ARVD/C-VT patients can share a left bundle branch block/inferior axis morphology.
Methods: We compared the electrocardiographic morphology of ventricular tachycardia or premature ventricular contractions with left bundle branch block/inferior axis pattern in 16 ARVD/C patients with that in 42 RVOT-VT patients.
Results: ARVD/C patients had a significantly longer mean QRS duration in lead I (150 ± 31 ms vs. 123 ± 34 ms, p = 0.006), more often exhibited a precordial transition in lead V(6) (3 of 17 [18%] vs. 0 of 42 [0%] with RVOT-VT, p = 0.005), and more often had at least 1 lead with notching (11 of 17 [65%] vs. 9 of 42 [21%], p = 0.001). The most sensitive characteristics for the detection of ARVD/C were a QRS duration in lead I of ≥120 ms (88% sensitivity, 91% negative predictive value). QRS transition at V(6) was most specific at 100% (100% positive predictive value, 77% negative predictive value). The presence of notching on any QRS complex had 79% sensitivity and 65% specificity of (55% positive predictive value, 85% negative predictive value). In multivariate analysis, QRS duration in lead I of ≥120 ms (odds ratio [OR]: 20.4, p = 0.034), earliest onset QRS in lead V(1) (OR: 17.0, p = 0.022), QRS notching (OR: 7.7, p = 0.018), and a transition of V(5) or later (OR: 7.0, p = 0.030) each predicted the presence of ARVD/C.
Conclusions: Several electrocardiographic criteria can help distinguish right ventricular outflow tract arrhythmias originating from ARVD/C compared with RVOT-VT patients.
The pivotal role of ECG in cardiomyopathies.
Silvetti E, Lanza O, Romeo F, Martino A, Fedele E, Lanzillo C Front Cardiovasc Med. 2023; 10:1178163.
PMID: 37404739 PMC: 10315483. DOI: 10.3389/fcvm.2023.1178163.
Brazilian Guidelines for Cardiac Implantable Electronic Devices - 2023.
Teixeira R, Fagundes A, Baggio Junior J, Oliveira J, Medeiros P, Valdigem B Arq Bras Cardiol. 2023; 120(1):e20220892.
PMID: 36700596 PMC: 10389103. DOI: 10.36660/abc.20220892.
Farre J, Rubio J, Sternick E Indian Pacing Electrophysiol J. 2022; 23(1):1-13.
PMID: 36473691 PMC: 9880893. DOI: 10.1016/j.ipej.2022.11.002.
Molitor N, Duru F J Clin Med. 2022; 11(5).
PMID: 35268321 PMC: 8911116. DOI: 10.3390/jcm11051230.
Hoffmayer K Heart Rhythm O2. 2021; 2(2):210-214.
PMID: 34113924 PMC: 8183866. DOI: 10.1016/j.hroo.2021.02.003.